Management of Small Cell Lung Cancer
Elsevier (Publisher)
Published in March 1990
Book
Hardback
216 pages
978-0-444-81217-9 (ISBN)
Description
The workshop on small cell lung cancer (SCLC) in June 1989, Elsinore, Denmark, was the third on this subject arranged by the International Association for the Study of Lung Cancer. Previous meetings were held in Ireland 1981 and Scotland 1984 and resulted in valuable contributions to the literature. The purpose of the third SCLC workshop was to reevaluate the available data on therapy in SCLC and to develop a consensus on important clinical topics. 63 colleagues were invited - all deeply involved in clinical research on SCLC. Seventeen nations from four continents were represented. Prior to the workshop 21 participants were asked to review the literature on particular topics and these reviews were distributed to all participants before the workshop. In addition all participants were invited to submit abstracts for internal use at the workshop only. Reviews and selected abstracts were presented as the basis of discussion in 6 plenary sessions. The discussions were continued in separate committees with the aim of reaching a written consensus. Finally, the content of the consensus reports was presented at a plenary session.
The workshop on small cell lung cancer (SCLC) in June 1989, Elsinore, Denmark, was the third on this subject arranged by the International Association for the Study of Lung Cancer. Previous meetings were held in Ireland 1981 and Scotland 1984 and resulted in valuable contributions to the literature. The purpose of the third SCLC workshop was to reevaluate the available data on therapy in SCLC and to develop a consensus on important clinical topics. 63 colleagues were invited - all deeply involved in clinical research on SCLC. Seventeen nations from four continents were represented. Prior to the workshop 21 participants were asked to review the literature on particular topics and these reviews were distributed to all participants before the workshop. In addition all participants were invited to submit abstracts for internal use at the workshop only. Reviews and selected abstracts were presented as the basis of discussion in 6 plenary sessions. The discussions were continued in separate committees with the aim of reaching a written consensus. Finally, the content of the consensus reports was presented at a plenary session.
The workshop on small cell lung cancer (SCLC) in June 1989, Elsinore, Denmark, was the third on this subject arranged by the International Association for the Study of Lung Cancer. Previous meetings were held in Ireland 1981 and Scotland 1984 and resulted in valuable contributions to the literature. The purpose of the third SCLC workshop was to reevaluate the available data on therapy in SCLC and to develop a consensus on important clinical topics. 63 colleagues were invited - all deeply involved in clinical research on SCLC. Seventeen nations from four continents were represented. Prior to the workshop 21 participants were asked to review the literature on particular topics and these reviews were distributed to all participants before the workshop. In addition all participants were invited to submit abstracts for internal use at the workshop only. Reviews and selected abstracts were presented as the basis of discussion in 6 plenary sessions. The discussions were continued in separate committees with the aim of reaching a written consensus. Finally, the content of the consensus reports was presented at a plenary session.
More details
Language
English
Place of publication
Oxford
United Kingdom
Publishing group
Elsevier Science & Technology
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 230 mm
ISBN-13
978-0-444-81217-9 (9780444812179)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Part I: Consensus Reports (7 papers). Part II: Invited Review Articles. I. Staging and Prognostic Factors (2 papers). II. Chemotherapy (7 papers). III. Local Treatment Modalities (3 papers). IV. Central Nervous System - Therapy (3 papers). V. Biological Modifiers (3 papers). VI. Complications and Supportive Care (3 papers).